Acrivon Traders Eye Cancer-Drug News Ahead of the Open
Acrivon Therapeutics shares edged lower in premarket trade Tuesday as the cancer drug maker prepared for a TD Cowen oncology event after the long holiday break. Shares on the Nasdaq finished Friday at $1.75, slipping 2.23%. The stock moved between $1.73 and $1.90 on 825,477 shares traded. StockAnalysis reported Acrivon at $1.74 in premarket trade at 4:38 a.m. EDT, off 0.57%.